Literature DB >> 22895883

Synthesis and properties of novel L-isonucleoside modified oligonucleotides and siRNAs.

Jun Zhang1, Yue Chen, Ye Huang, Hong-Wei Jin, Ren-Ping Qiao, Lei Xing, Liang-Ren Zhang, Zhen-Jun Yang, Li-He Zhang.   

Abstract

Antisense oligonucleotides and siRNAs are potential therapeutic agents and their chemical modifications play an important role to improve the properties and activities of oligonucleotides. Isonucleoside is a type of nucleoside analogue, in which the nucleobase is moved from C-1 to other positions of ribose. In this report, a novel isonucleoside 5 containing a 5'-CH(2)-extended chain at the sugar moiety was synthesized, thus isoadenosine 5a and isothymidine 5b were incorporated into a DNA single strand and siRNA. It was found that isonucleoside 5 modified oligonucleotides can form stable double helical structures with their complementary DNA and RNA and the stability towards nuclease and ability to activate RNase H are more promising compared with the unmodified, natural analogues. In siRNA, passenger strand modified with isonucleoside (5a/b) at 3' or 5' terminal can retain the silencing activity and minimize the passenger strand specific off-target effect.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895883     DOI: 10.1039/c2ob26219c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  1 in total

1.  The Bioactivity of D-/L-Isonucleoside- and 2'-Deoxyinosine-Incorporated Aptamer AS1411s Including DNA Replication/MicroRNA Expression.

Authors:  Xinmeng Fan; Lidan Sun; Kunfeng Li; Xiantao Yang; Baobin Cai; Yanfen Zhang; Yuejie Zhu; Yuan Ma; Zhu Guan; Yun Wu; Lihe Zhang; Zhenjun Yang
Journal:  Mol Ther Nucleic Acids       Date:  2017-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.